Log In
BCIQ
Print this Print this
 

Fosamax Plus D, alendronate sodium/cholecalciferol

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionBisphosphonate plus vitamin D
Molecular Target Not available
Mechanism of ActionInhibits bone resorption
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationOsteoporosis
Indication DetailsReduce the risk of hip and spine fractures in postmenopausal women with osteoporosis plus a weekly dose of vitamin D; Treat osteoporosis in postmenopausal women and increase bone mass in men with osteoporosis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today